“ Treatment With Dasatinib or Nilotinib in Chronic Myeloid Leukemia Patients Who Failed to Respond to Two Previously Administered Tyrosine Kinase Inhibitors - a Single Center Experience ”. 2015. Clinics 70 (8): 550-55. https://doi.org/10.6061/clinics/2015(08)04.